Cannabis Schedule III rescheduling marks a major shift in how cannabis is classified and understood at the federal level. This change begins to align policy with clinical reality, affecting research, documentation, and patient access. Cannabis Schedule III rescheduling does not solve every clinical challenge, but it opens the door to more structured and evidence-driven care.